Sign up to save your podcasts
Or
Share Maximizing B-Cell Lymphoma Outcomes with CAR T-Cell Therapy and Personalized Care
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Maximizing B-Cell Lymphoma Outcomes with CAR T-Cell Therapy and Personalized Care
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Tara Graff, DO, MS
The therapeutic landscape for relapsed or refractory B-cell lymphoma has greatly evolved in the past several years, with CAR T-cell therapy and personalized care becoming increasingly important in the second-line setting. Joining Dr. Charles Turck to discuss how CAR T-cell therapy and patient-centered care can help optimize outcomes in the second-line treatment of patients with B-cell lymphoma is medical oncologist Dr. Tara Graff.
View all episodes
By ReachMD
4.5
22 ratings
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Tara Graff, DO, MS
The therapeutic landscape for relapsed or refractory B-cell lymphoma has greatly evolved in the past several years, with CAR T-cell therapy and personalized care becoming increasingly important in the second-line setting. Joining Dr. Charles Turck to discuss how CAR T-cell therapy and patient-centered care can help optimize outcomes in the second-line treatment of patients with B-cell lymphoma is medical oncologist Dr. Tara Graff.